Polysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol

Sci Rep. 2016 Jan 13:6:19212. doi: 10.1038/srep19212.

Abstract

The construction of synthetic straightforward, biocompatible and biodegradable targeted drug delivery system with fluorescent tracking abilities, high anticancer activities and low side effects is still a challenge in the field of biochemistry and material chemistry. In this work, we constructed targeted paclitaxel (Taxol) delivery nanoparticles composed of permethyl-β-cyclodextrin modified hyaluronic acid (HApCD) and porphyrin modified paclitaxel prodrug (PorTaxol), through host-guest and amphiphilic interactions. The obtained nanoparticles (HATXP) were biocompatible and enzymatic biodegradable due to their hydrophilic hyaluronic acid (HA) shell and hydrophobic Taxol core, and exhibited specific targeting internalization into cancer cells via HA receptor mediated endocytosis effects. The cytotoxicity experiments showed that the HATXP exhibited similar anticancer activities to, but much lower side effects than commercial anticancer drug Taxol. The present work would provide a platform for targeted paclitaxel drug delivery and a general protocol for the design of advanced multifunctional nanoscale biomaterials for targeted drug/gene delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Biocompatible Materials / chemistry
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Delivery Systems*
  • Humans
  • Materials Testing
  • Mice
  • NIH 3T3 Cells
  • Nanoparticles / chemistry
  • Nanoparticles / ultrastructure
  • Paclitaxel / administration & dosage*
  • Polysaccharides / chemistry*
  • beta-Cyclodextrins / chemistry

Substances

  • Antineoplastic Agents, Phytogenic
  • Biocompatible Materials
  • Drug Carriers
  • Polysaccharides
  • beta-Cyclodextrins
  • Paclitaxel